EUVIMEDEUVIMED entdecken
Crossref

Cicatrizing Conjunctivitis: An Overview of Pathology, Market Sizes, Current Treatments, and Tissue Engineering Approaches

Bill Tawil

Scholastic Medical Sciences · 30.03.2025 · 01

DOI: 10.67735/scms.2025.02.0096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scholastic Medical Sciences, online erschienen am 30.03.2025. Verfasst von Bill Tawil.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cicatrizing conjunctivitis (CC) is a progressive, vision-threatening disease characterized by fibrosis of the conjunctiva that, if left untreated, can lead to permanent ocular damage and blindness. It has various etiologies, including autoimmune disorders, infections, or trauma. The conjunctiva is a dynamic mucosal membrane composed of a stratified epithelium, goblet cells, lymphoid tissue, and a vascularized stromal matrix supporting lubrication, immune defense, and constant regeneration. A diseased conjunctiva due to CC is characterized by immune-mediated goblet cell loss, fibroblast activation, and pro-fibrotic cytokine signaling that leads to scarring, loss of tear film integrity, and vision impairment. Current treatments involve amniotic membrane grafts, mucosal grafts, and stem cell therapies in conjunction with systemic immunosuppression and/or topical ther- apies, but these are limited by donor variability, inflammation, or relapse of fibrosis. Newly found tissue-engineering strategies, such as COMET, SOMET, Holoclar, CALEC, and emerging MSC-based therapies, are promising regenerative approaches that solve the issues that arise in previous therapies. This review highlights the pathophysiology of healthy and diseased conjunctiva and evaluates current treatments while providing a mar- ket analysis for these regenerative treatment options.

Zitieren

APA

Tawil, B. (2025). Cicatrizing Conjunctivitis: An Overview of Pathology, Market Sizes, Current Treatments, and Tissue Engineering Approaches. Scholastic Medical Sciences, 01. https://doi.org/10.67735/scms.2025.02.0096

Vancouver

Tawil B. Cicatrizing Conjunctivitis: An Overview of Pathology, Market Sizes, Current Treatments, and Tissue Engineering Approaches. Scholastic Medical Sciences. 2025:01. doi:10.67735/scms.2025.02.0096

BibTeX
@article{Tawil2025,
  author = {Tawil, Bill},
  title = {Cicatrizing Conjunctivitis: An Overview of Pathology, Market Sizes, Current Treatments, and Tissue Engineering Approaches},
  journal = {Scholastic Medical Sciences},
  year = {2025},
  pages = {01},
  doi = {10.67735/scms.2025.02.0096}
}
Kostenlos starten →